OFFER OF EMPLOYMENTExecutive Employment Agreement |
|
|
|
You are currently viewing: This Executive Employment Agreement involves
BIOSPHERE MEDICAL INC. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here. |
|
|
|
Search Executive Employment Agreement by:
Exhibit 10.3
June 14, 2005
Peter C. Sutcliffe
317 Tamarac Lane
Abington, MA 02351
Dear Peter:
We are pleased to offer you continued employment with BioSphere Medical, Inc. (the “Company”) under the following terms and conditions. As consideration for your execution of this letter agreement, the Company will grant you a stock option to purchase 150,000 shares of the Company’s Common Stock, $.01 par value per share (“Common Stock”), as described below in paragraph 3. This agreement will supercede the terms of any prior agreements purporting to set forth the terms and conditions of your employment.
1.
Employment; Location; Duties.
You will continue to be employed to serve on a full-time basis as Vice President, Operations, and will continue to be based at the Company’s headquarters. You will continue to be subject to the supervision of, and shall have such authority as is delegated to you by, the Chief Executive Officer of the Company.
By entering into this letter agreement with the Company, you will be agreeing to undertake the duties and responsibilities inherent in such position and such other duties and responsibilities as the Chief Executive Officer shall from time to time reasonably assign to you. You agree to devote your entire business time, attention and energies to the business and interests of the Company during your continued employment. You also agree to abide by the rules, regulations, instructions, personnel practices and policies of the Company and any changes therein which may be adopted from time to time by the Company.
2.
Compensation.
2.1
Base Salary. Your annualized base salary
will continue to be $189,960, less applicable taxes and withholdings, paid
semi-monthly in accordance with the Company’s payroll practices
(“Base Salary”). Such salary and pay schedule may be
adjusted from time to time, in accordance with normal business practice and in
the sole discretion of the Company’s Board of Directors.
2.2
Bonus. You will be eligible to
receive an annual bonus in an amount equal to up to 30% of your then current
Base Salary, to be paid based upon the Company’s evaluation of your
achievement of milestones and objectives to be mutually agreed upon annually by
you and the Compensation Committee of the Board of Directors, provided that you
remain an employee of the Company at the time such bonuses are customarily
paid.
2.3
Other Benefits. You shall continue to be eligible
to participate in all benefit programs that the Company establishes and
generally makes available to its employees, if any, to the extent that your
position, tenure, salary, age, health and other qualifications make you
eligible to participate, including but not limited to the Company’s
health insurance plan, 401(k) plan, and policies governing paid time off.
In addition, you shall continue to be entitled to three (3) weeks paid
vacation per year, subject to the Company’s policies and procedures, to
be taken at such times as may be approved by the Company’s Chief
Executive Officer or his designee. The Company reserves the right to amend
and/or terminate any plan, benefit, or program at any time with or without
notice or publication.
2.4
Reimbursement of
Expenses.
The Company shall reimburse you for all reasonable travel, entertainment and
other expenses incurred or paid by you in connection with, or related to, the
performance of your duties, responsibilities or services as an employee of the
Company, in accordance with policies and procedures, and subject to
limitations, adopted by the Company from time to time.
3.
Consideration.
If you enter into this letter agreement with the Company, you will be granted, pursuant to the Company’s 1997 Stock Incentive Plan (the “Plan”) (a) an option to purchase 100,000 shares of Common Stock of the Company pursuant to the terms and conditions of the Plan and a stock option agreement issued thereunder, such option to be exercisable at a price per share equal to the closing price of the Company’s Common Stock on the NASDAQ Stock Market on date of grant, such option to vest and become exercisable, subject to your continued employment, at a rate of 20% of the total shares underlying the option on the first anniversary of the date of grant and as to an additional 20% at the end of each full year thereafter and (b) an option, to purchase 50,000 shares of the Company’s Common Stock pursuant to the terms and conditions of the Plan and a stock option agreement issued thereunder, such option to be exercisable at a price per share equal to the closing price of the Company’s Common Stock on the date of grant, such option to vest and become exercisable, subject to your continued employment, at a rate of 33.3333% of the total shares underlying the option on the first anniversary of the date on which the Company books revenue from the commercial sale of its products in excess of $25.0 million (as reflected on the Company’s financial statements prepared in accordance with generally accepted accounting principles in the United States) in any continuous 12-month period and as to an additional 33.3333% at the end of each full year thereafter; provided that such option shall vest, in any event, on the end of the seventh year after the date of grant.
4.
Termination Upon or in Anticipation of
a Change in Control.
4.1
In the event your
at-will employment is terminated by the Company without Cause (as defined
below) in anticipation of, or within twelve months after, a Change in Control
(as defined below), the Company shall continue to pay to you your salary as in
effect on the date of termination and the amount of the annual bonus paid to
you for the fiscal year immediately preceding the date of termination (payable
in annualized monthly installments) and shall, provided you elect to receive
group medical insurance pursuant to the federal “COBRA”
law, 29 U.S.C. § 1161 et seq.,
provide to you reimbursement for the share of the premium for group medical and
dental that is paid by the Company for active and similarly-situated employees
who receive the same type of coverage, until the date 12 months after the date
of termination, provided, however, that the Company’s obligation to make
the aforesaid payments or provide the aforesaid benefits shall immediately
terminate in the event that you violate the provisions of Section 5 or
Section 6 of this letter agreement during such 12 month period. The
payment to you of the amounts payable under this Section 4.1 shall be
contingent upon your execution of a release in a form reasonably acceptable to
and prepared by the Company and (ii) shall constitute your sole remedy in
the event of a termination of your employment in the circumstances set forth in
this Section 4.1.
4.2
“Cause”
shall, for the purposes of Section 4.1, mean (a) a finding by the
Company of failure by you to perform your assigned duties for the Company,
dishonesty, gross negligence, misconduct, or any act or omission by you that
may have an adverse effect on the Company’s business or on your ability
to perform services for the Company; or (b) your conviction or the entry
of a pleading of guilty or nolo contendere to any crime involving moral
turpitude or any felony.
4.3
“Change in Control”
means an event or occurrence set forth in any one or more of subsections
(a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a)
the acquisition by an
individual, entity or group (within the meaning of
Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of
1934, as amended (the “Exchange Act”)) (a “Person”) of
beneficial ownership of any capital stock of the Company if, after such
acquisition, such Person beneficially owns (within the meaning of
Rule 13d-3 promulgated under the Exchange Act) 50% or more of either (x)
the then-outstanding shares of common stock of the Company (the “Outstanding
Company Common Stock”) or (y) the combined voting power of the
then-outstanding securities of the Company entitled to vote generally in the
election of directors (the “Outstanding Company Voting
Securities”); provided, however, that for purposes of this
subsection (a), the following acquisitions shall not constitute a Change
in Control: (i) any acquisition directly from the Company (excluding an
acquisition pursuant to the exercise, conversion or exchange of any security
exercisable for, convertible into or exchangeable for common stock or voting
securities of the Company, unless the Person exercising, converting or
exchanging such security acquired such security directly from the Company or an
underwriter or agent of the Company), (ii) any acquisition by the Company,
(iii) any acquisition by any employee benefit plan (or related trust)
sponsored or maintained by the Company or any corporation controlled by the
Company, or (iv) any acquisition by any corporation pursuant to a transaction
which complies with clauses (i) and (ii) of
subsection (c) of this Section 4.3; or
(b)
such time as the
Continuing Directors (as defined below) do not constitute a majority of the
Board (or, if applicable, the Board of Directors of a successor corporation to
the Company), where the term “Continuing Director” means at any
date a member
of the Board (i) who was a member of the Board on the
date of the execution of this letter agreement or (ii) who was nominated
or elected subsequent to such date by at least a majority of the directors who
were Continuing Directors at the time of such nomination or election or whose
election to the Board was recommended or endorsed by at least a majority of the
directors who were Continuing Directors at the time of such nomination or
election; provided, however, that there shall be excluded from
this clause (ii) any individual whose initial assumption of office
occurred as a result of an actual or threatened election contest with respect
to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Board; or
(c)
the consummation of a
merger, consolidation, reorganization, recapitalization or statutory share
exchange involving the Company or a sale or other disposition of all or
substantially all of the assets of the Company in one or a series of
transactions (a “Business Combination”), unless, immediately
following such Business Combination, each of the following two conditions is
satisfied: (i) all or substantially all of the individuals and entities
who were the beneficial owners of the Outstanding Company Common Stock and
Outstanding Company Voting Securities immediately prior to such Business
Combination beneficially own, directly or indirectly, more than 50% of the
then-outstanding shares of common stock and the combined voting power of the
then-outstanding securities entitled to vote generally in the election of
directors, respectively, of the resulting or acquiring corporation in such
Business Combination (which shall include, without limitation, a corporation
which as a result of such transaction owns the Company or substantially all of
the Company’s assets either directly or through one or more subsidiaries)
(such resulting or acquiring corporation is referred to herein as the
“Acquiring Corporation”) in substantially the same proportions as
their ownership, immediately prior to such Business Combination, of the
Outstanding Company Common Stock and Outstanding Company Voting Securities,
respectively; and (ii) no Person (excluding any employee benefit plan (or
related trust) maintained or sponsored by the Company or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 50% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors (except to the extent
that such ownership existed prior to the Business Combination); or
(d)
approval by the
stockholders of the Company of a complete liquidation or dissolution of the
Company.
5.
Non-Competition and Non-Solicitation.






